According to a story from BioPortfolio, Acceleron Pharma and the Bristol-Myers Squibb Company have announced recently that the US Food and Drug Administration (FDA) will review the supplemental Biologics License…
According to a story from Business Wire, the biopharmaceutical company Bristol-Myers Squibb has recently announced that the US Food and Drug Administration (FDA) has granted the company's drug abatacept (marketed…
The iPain Summit 2019 took place from November 14th-16th, 2019. Patient Worthy had the privilege to attend this event and cover it live on social media. This summit was focused…
A new clinical trial will be conducted at The Center for Neurology of the Academic Specialist Center (ASC) in tandem with the Karolinska Institute. This study is meant to…
Surufatinib was recently granted Orphan Drug designation by the FDA. This drug was made for the treatment of pancreatic neuroendocrine tumors (PanNETs). It was created by Hutchison China MediTech…
At the International Pain Foundation's iPain Summit, held this year from November 14th-16th, a wide variety of topics related to the challenges faced by patients with chronic pain were discussed.…
As reported in the Guardian, at Bath University, scientists have created a groundbreaking technology for the future of medication: artificial nerve cells or neurons created on silicon to replace deteriorating…
According to a story from tmcnet.com, the biopharmaceutical company Immunovant has just announced that beginning of patient dosing in its phase 2b clinical trial. This clinical trial will test the…
In a meeting with some of the world's brightest medical minds, the importance of personalized treatment for inflammatory bowel disease was discussed. At the 14th Annual Congress of the…
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
